Modalis Therapeutics Corporation (4883) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-08-14 | Earnings Release | (Correction) Regarding Corrections to the "Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]" | |
| 2026-08-14 | — | (Further Correction) Notice Concerning Corrections to Business and Financial report for Six Months Ended June 30, 2026 | |
| 2026-08-10 | — | (Correction) Notice Concerning Corrections to Business and Financial report for Six Months Ended June 30, 2026 | |
| 2026-08-10 | Earnings Release | Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP] | |
| 2026-08-10 | — | Business and Financial report for Six Months Ended June 30, 2026 | |
| 2026-08-10 | — | Notice Regarding the Recording of Non-Operating Income and Extraordinary Income | |
| 2026-07-14 | — | Business Plans and Matters Related to Growth Potential |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.